16.63 -1.69 (-9.22%)

81.92% Fall from 52W High

73,681 XNAS Volume

XNAS 03 Apr, 2025 5:30 PM (EDT)



Insider Trading disclosures for Instil Bio Inc

The latest disclosure was made by Bronson Crouch in Instil Bio Inc where a trade of 50,000 Employee Stock Option (right to buy) done was reported to US exchanges on Sept. 18, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Bronson Crouch Director, CEO and Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2024 50,000 50,000 - - Employee Stock Option (right to buy)
Sandeep Laumas CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2024 45,000 45,000 - - Employee Stock Option (right to buy)
George Matcham Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,000 5,000 - - Stock Option (Right to Buy)
R. Kent McGaughy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,000 5,000 - - Stock Option (Right to Buy)
Gwendolyn K. Binder-Scholl Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,000 5,000 - - Stock Option (Right to Buy)
Neil Gibson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,000 5,000 - - Stock Option (Right to Buy)
Bronson Crouch Director, CEO and Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2024 120,000 120,000 - - Employee Stock Option (right to buy)
Laumas Sandeep CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2024 80,000 80,000 - - Employee Stock Option (right to buy)
Binder-Scholl Gwendolyn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 1,500 1,500 - - Stock Option (Right to Buy)
Nielsen Jack Bech Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 1,500 1,500 - - Stock Option (Right to Buy)
Gibson Neil Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 1,500 1,500 - - Stock Option (Right to Buy)
Matcham George Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 1,500 1,500 - - Stock Option (Right to Buy)
McGaughy R. Kent Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 1,500 1,500 - - Stock Option (Right to Buy)
Sumita Ray Chief Legal and Admin Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2023 415,000 415,000 - - Employee Stock Option (right to buy)
Ray Sumita Chief Legal and Admin Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2023 50,000 50,000 - - Employee Stock Option (right to buy)
Crouch Bronson Director, CEO and Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2023 1,000,000 1,000,000 - - Employee Stock Option (right to buy)
Laumas Sandeep CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jan 2023 415,000 415,000 - - Employee Stock Option (right to buy)
Timothy L. Moore Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Sep 2022 750,000 750,000 - - Employee Stock Option (right to buy)
George Matcham Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 30,000 30,000 - - Employee Stock Option (right to buy)
Vijay Chiruvolu Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 154,237 154,237 - - Employee Stock Option (right to buy)
R. Kent McGaughy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 30,000 30,000 - - Employee Stock Option (right to buy)
Gwendolyn Binder-Scholl Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 30,000 30,000 - - Employee Stock Option (right to buy)
Jack Bech Nielsen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 30,000 30,000 - - Employee Stock Option (right to buy)
Neil Gibson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 30,000 30,000 - - Employee Stock Option (right to buy)
R. Kent McGaughy Director Other type of transaction at price $ 0.00 per share. 15 Mar 2022 260,323 8,218,467 - 0 Common Stock
Vijay Chiruvolu Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2022 257,000 257,000 - - Employee Stock Option (right to buy)
Zachary Roberts Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2022 245,000 245,000 - - Employee Stock Option (right to buy)
Bronson Crouch Director, CEO and Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2022 750,000 750,000 - - Employee Stock Option (right to buy)
Sandeep Laumas CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2022 234,000 234,000 - - Employee Stock Option (right to buy)
Zachary Roberts Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Oct 2021 120,000 240,000 - - Employee Stock Option (right to buy)
Zachary Roberts Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Sep 2021 120,000 120,000 - - Employee Stock Option (right to buy)
Sandeep Laumas CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 200,000 200,000 - - Employee Stock Option (right to buy)
Bronson Crouch Director, CEO and Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 750,000 750,000 - - Employee Stock Option (right to buy)
Zachary Roberts Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 200,000 200,000 - - Employee Stock Option (right to buy)
Vijay Chiruvolu Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 200,000 200,000 - - Employee Stock Option (right to buy)
Vijay Chiruvolu Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 154,237 154,237 - - Employee Stock Option (right to buy)
Nimish Shah Director Purchase of securities on an exchange or from another person at price $ 20.00 per share. 23 Mar 2021 10,470 563,533 - 20 209,400 Common Stock
Nimish Shah Director 23 Mar 2021 5,100,866 5,100,866 - - Common Stock
Bronson Crouch Director, CEO and Chairman, Ten Percent Owner 23 Mar 2021 30,000,000 30,000,000 - - Common Stock
Bronson Crouch Director, CEO and Chairman, Ten Percent Owner 23 Mar 2021 6,098,799 36,098,799 - - Common Stock
Bronson Crouch Director, CEO and Chairman, Ten Percent Owner 23 Mar 2021 1,431,274 37,530,073 - - Common Stock
Bronson Crouch Director, CEO and Chairman, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 20.00 per share. 23 Mar 2021 450,000 37,980,073 - 20 9,000,000 Common Stock
Bronson Crouch Director, CEO and Chairman, Ten Percent Owner 23 Mar 2021 1,192,729 0 - - Series C Preferred Stock
Bronson Crouch Director, CEO and Chairman, Ten Percent Owner 23 Mar 2021 5,082,333 0 - - Series B Preferred Stock
Bronson Crouch Director, CEO and Chairman, Ten Percent Owner 23 Mar 2021 25,000,000 0 - - Series A Preferred Stock
R. Kent McGaughy Director 23 Mar 2021 954,182 8,028,790 - - Common Stock
R. Kent McGaughy Director Purchase of securities on an exchange or from another person at price $ 20.00 per share. 23 Mar 2021 450,000 8,478,790 - 20 9,000,000 Common Stock
R. Kent McGaughy Director 23 Mar 2021 5,895,507 0 - - Series B Preferred Stock
R. Kent McGaughy Director 23 Mar 2021 795,152 0 - - Series C Preferred Stock
R. Kent McGaughy Director 23 Mar 2021 7,074,608 7,074,608 - - Common Stock
Jack B. Nielsen Director 23 Mar 2021 397,576 0 - - Series C Preferred Stock
Jack B. Nielsen Director Purchase of securities on an exchange or from another person at price $ 20.00 per share. 23 Mar 2021 300,000 12,486,787 - 20 6,000,000 Common Stock
Jack B. Nielsen Director 23 Mar 2021 477,091 12,186,787 - - Common Stock
Jack B. Nielsen Director 23 Mar 2021 11,709,696 11,709,696 - - Common Stock
Jack B. Nielsen Director 23 Mar 2021 9,758,080 0 - - Series B Preferred Stock
Nimish Shah Director 23 Mar 2021 510,030 510,030 - - Common Stock
Nimish Shah Director Purchase of securities on an exchange or from another person at price $ 20.00 per share. 23 Mar 2021 48,390 48,390 - 20 967,800 Common Stock
Nimish Shah Director Purchase of securities on an exchange or from another person at price $ 20.00 per share. 23 Mar 2021 19,620 19,620 - 20 392,400 Common Stock
Nimish Shah Director 23 Mar 2021 4,250,722 0 - - Series B Preferred Stock
Nimish Shah Director 23 Mar 2021 425,025 0 - - Series B Preferred Stock
Nimish Shah Director 23 Mar 2021 358,693 0 - - Series C Preferred Stock
Nimish Shah Director 23 Mar 2021 35,861 0 - - Series C Preferred Stock
Nimish Shah Director 23 Mar 2021 400,597 0 - - Series C Preferred Stock
Nimish Shah Director Purchase of securities on an exchange or from another person at price $ 20.00 per share. 23 Mar 2021 104,640 5,635,937 - 20 2,092,800 Common Stock
Nimish Shah Director 23 Mar 2021 480,716 480,716 - - Common Stock
Nimish Shah Director 23 Mar 2021 43,033 553,063 - - Common Stock
Nimish Shah Director 23 Mar 2021 430,431 5,531,297 - - Common Stock
Nimish Shah Director Purchase of securities on an exchange or from another person at price $ 20.00 per share. 23 Mar 2021 116,880 597,596 - 20 2,337,600 Common Stock
Vijay Chiruvolu Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 240,000 240,000 - - Employee Stock Option (right to buy)
Zachary Roberts Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 240,000 240,000 - - Employee Stock Option (right to buy)
Bronson Crouch Director, CEO and Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 1,200,000 1,200,000 - - Employee Stock Option (right to buy)
Sandeep Laumas CFO and CBO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 240,000 240,000 - - Employee Stock Option (right to buy)
R. Kent McGaughy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 52,000 52,000 - - Stock Option (right to buy)
Gwendolyn Binder-Scholl Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 52,000 52,000 - - Stock Option (right to buy)
Jack B. Nielsen Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 52,000 52,000 - - Stock Option (right to buy)
Neil Gibson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 52,000 52,000 - - Stock Option (right to buy)
George Matcham Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 52,000 52,000 - - Stock Option (right to buy)
Nimish Shah Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 52,000 52,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures